Cleared Traditional

K935254 - DVVTEST AND DVVCONFIRM LUPUS ANTICOAGULANT NORMAL AND ABNORMAL CONTROL PLASMA

K935254 is an FDA 510(k) clearance for DVVTEST AND DVVCONFIRM LUPUS ANTICOAGUL..., manufactured by American Diagnostica, Inc.. The device is a Class 2 Hematology device with product code GIZ cleared through the Traditional 510(k) pathway after a 322-day FDA review.

K935254 · American Diagnostica, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
322d
Days
Class 2
Risk

K935254 is an FDA 510(k) clearance for the DVVTEST AND DVVCONFIRM LUPUS ANTICOAGULANT NORMAL AND ABNORMAL CONTROL PLASMA. Classified as Plasma, Control, Normal (product code GIZ), Class II - Special Controls.

Submitted by American Diagnostica, Inc. (Greenwich, US). The FDA issued a Cleared decision on September 19, 1994 after a review of 322 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all American Diagnostica, Inc. devices

FDA 510(k) Submission Details - K935254

510(k) Number K935254 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 1993
Decision Date September 19, 1994
Days to Decision 322 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
209d slower than avg
Panel avg: 113d · This submission: 322d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GIZ Device Classification - Class 2, Special Controls

Product Code GIZ Plasma, Control, Normal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GIZ Plasma, Control, Normal

All 17
Devices cleared under the same product code (GIZ) and FDA review panel - the closest regulatory comparables to K935254.
ACCUCOLOR HIGH CALIBRATOR (A3089)
K973274 · Sigma Diagnostics, Inc. · Oct 1997
THROMBOLYTIC ASSESSMENT SYSTEM PROTHROMBIN TIME TEST CONTROLS
K961814 · Cardiovascular Diagnostics, Inc. · Aug 1996
SPECIALTY ASSAYED CONTROL-1
K941737 · Helena Laboratories · Oct 1994
CONTROL PLASMA N
K924403 · Behring Diagnostics, Inc. · Feb 1994
COAGULATION REFERENCE PLASMA, NORMAL
K932145 · American Diagnostic Corp. · Oct 1993
UNICALIBRATOR KIT
K922021 · American Bioproducts Co. · Jun 1992